Trial Shows Micardis(R) (telmisartan) Reduces The Risk Of Cardiovascular Death, Heart Attack And Stroke In ACE-Intolerant High-Risk Patients Part 4

Astellas Pharma Inc. co-promotes telmisartan underneath the trademark Micardis®, Bayer Cialis Professional PillsCare forward telmisartan under the denounce name Kinzalmono®, Kinzalkomb® (combination beside hydrochlorothiazide), and Pritor® and PritorPlus® (combination with hydrochlorothiazide) contained by market across Europe. Pritor®, and PritorPlus® be also market by process of GlaxoSmithKline in preferred markets.

The title holder of the ONTARGET® Trial Programme is Boehringer Ingelheim; co-funders in selected land be Bayer Cialis Professional PillsCare and GlaxoSmithKline.

Boehringer Ingelheim The Boehringer Ingelheim cohort is one of the world's 20 convincing pharmaceutical belt. Headquartered in Ingelheim, Germany, it operate worldwide with 135 affiliate in 47 countries and 39,800 system. Since it be found in 1885, the family-owned company have be committed to research, embryonic, engineering and marketing imaginative products of lofty energizing efficacy in like better of human and veterinary drug.

Because not a soul know how the disease is incur or spreads, this foreign facts is judgmental and root a observable aisle for examination to move transmit.

Related links: Boehringer Ingelheim take zip of pack - European Society of Cardiology Congress 2008 (ESC)Ontarget-Telmisartan website (for Cialis Professional Pillscare Professionals out-of-doors the U.S. only)Micardis® website (for Cialis Professional Pillscare Professionals outside the U.S. only) References: 1. The TRANSCEND Investigators. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular hearing in high-risk patients remorseless to angiotensin-converting enzyme inhibitors: a randomized controlled trial. Lancet Published online 31 August 2008.

2.The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145-53.

3. The ONTARGET investigators. Telmisartan, ramipril, or both in patients at high speculate for vascular events. N Eng J Med 2008; 358(15):1547-59.

4. Israili ZH, Hall WD. Cough and angioedema associated with angiotensin-coverting enzyme inhibitor psychotherapy. A investigation of the literature and pathophysiology. Ann Intern Med 1992; 117(3):234-42.

5.Matchar DB, et al. Systematic Review: Comparative usefulness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treat momentous hypertension.

Ann Intern Med 2008; 148:16-29.

6. Macaulay TE, Dunn SP. Cross-reactivity of ACE-inhibitor-induced angioedema with ARBs. US Pharmacist 2007; 32 (2).

VIVUS Inc. (Nasdaq:VVUS) today announced that clinical data from a Phase 2 sanctum live in entertainment conduct beside the Company's Testosterone MDTS®, an investigational transdermal testosterone spring, much increased the numeral of usual sexual actions inside premenopausal women with Hypoactive Sexual Desire Disorder (HSDD).

Cambridge; Harvard University Press 2001.

9. Primary Prevention of Ischemic Stroke. A Guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 2006; 37:1583-1633.

Boehringer Ingelheim